Vetter News

Photovoltaik auf dem neuen Lagergebäude
Strategy & Company
Vetter joins Science Based Targets Initiative (SBTi)

We continue to drive our sustainability strategy forward.

12/05/2023

High quality standards in aseptic production at Vetter’s clinical site in Vorarlberg, Austria
Strategy & Company
Vetter Development Service Rankweil successfully completes re-inspection

Vetter’s European clinical site receives permanent Manufacturer’s Authorization

11/09/2023

Work in progress at Vetter´s site in Ravensburg.
Strategy & Company
Vetter looks ahead to further expansions to meet supply chain demand

Ongoing investments in the supply chain for complex injectable medications

10/17/2023

Strategy & Company
We won Frost & Sullivan’s Customer Value Award for the 3rd time

Identified as best-in-class CDMO in global biopharmaceutical aseptic fill-and-finish services

08/29/2023

Vetter Gold Status Best Managed Company Awards 2023
Strategy & Company
Gold status for Vetter: Named Best Managed Company for the fourth time

Vetter honored as an exceptionally managed company.

05/30/2023

Vetter continues to drive the expansion of capacities and services for the provision of clinical trial materials at its Austrian site
Strategy & Company
High demand: Vetter expands production capacities and services offered at its Austrian site

Vetter further expands offerings for clinical development and manufacturing.

05/09/2023

Going to market in an autoinjector
Strategy & Company
Upcoming free webcast: “Going to Market in an Autoinjector”

03/31/2023

Vetter as one winner at the CDMO leadership awards 2023
Strategy & Company
Vetter Performs Extraordinarily with Six Wins in the 12th Annual CDMO Leadership Awards

Vetter honored as winner in all six core award categories.

03/27/2023

Vetter has been pursuing an ambitious sustainability strategy for years
Strategy & Company
CDMO joins United Nations Global Compact

Vetter strengthens worldwide commitment to sustainable business practices

03/06/2023

Supporting efficient drug development with dedicated clinical development expertise
Strategy & Company
Vetter’s Clinical Facility Demonstrates Success with 5 Client Products on the Market

Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development

02/01/2023

The new fully automated Vetter warehouse
Strategy & Company
New fully automated Vetter warehouse expands storage and boosts logistical infrastructure

Additional investments across the company support customer supply needs

10/27/2022

Material preparation at Vetter Rankweil site
Strategy & Company
Newest clinical manufacturing site successfully completed its first customer fills

Vetter Development Services Rankweil is poised for expansion.

06/27/2022